RCKT- Rocket Pharmaceuticals, Inc.

Name: Rocket Pharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Rocket Pharmaceuticals, Inc. (RCKT) has 10 insiders with recent SEC Form 4 filings, including 5 buys and 9 sells. RCKT is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Rtw Investments, LP	19.19M	$66.39M	-
CEO	Shah Gaurav	778.3K	$2.69M	-
COO	Stevens Christopher James	407.2K	$1.41M	-
Other	Wilson Martin	383.8K	$1.33M	-
Other	Schwartz Jonathan David	299.1K	$1.03M	-

Activity

Buys and sells only

Transactions

10 filings · page 9

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
May 11, 2021	Rtw Investments, LP63	Director, 10% Owner	Sell	725,000	$40.03	$29,023,490.00	-4.5%	-20.0%	-81.1%
Dec 28, 2020	Patel Kinnari69	Chief Operating Officer	Sell	16,761	$56.72	$950,744.72	-7.9%	-	-
Dec 10, 2020	Rtw Investments, LP63	-	Buy	247,720	$56.00	$13,872,320.00	+1.4%	-	-
Mar 18, 2020	Patel Kinnari69	Chief Operating Officer	Buy	1,000	$9.50	$9,500.00	+17.6%	-	-
Dec 10, 2019	Rtw Investments, LP63	Director, 10% Owner	Buy	225,000	$22.25	$5,006,250.00	+1.3%	-	-
Apr 16, 2019	Rtw Investments, LP63	Director, 10% Owner	Buy	550,005	$17.50	$9,625,087.50	+3.3%	-	-
Mar 5, 2019	Shah Gaurav71	See Remarks	Sell	74,900	$17.17	$1,286,272.00	-3.4%	-	-
Dec 13, 2018	Southwell David P69	Director	Sell	38,768	$15.19	$588,885.92	-28.9%	-	-
Dec 7, 2018	Southwell David P69	Director	Sale+OE	57,732	$15.13	$873,458.28	-17.5%	-	-
Dec 6, 2018	Patel Kinnari69	Chief Operating Officer	Buy	5,675	$14.98	$85,011.50	New	-	-

← PrevPage 9Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC